HU182562B - Process for preparing new 4-amino-2-piperidino-quinazoline derivatives - Google Patents

Process for preparing new 4-amino-2-piperidino-quinazoline derivatives Download PDF

Info

Publication number
HU182562B
HU182562B HU79PI678A HUPI000678A HU182562B HU 182562 B HU182562 B HU 182562B HU 79PI678 A HU79PI678 A HU 79PI678A HU PI000678 A HUPI000678 A HU PI000678A HU 182562 B HU182562 B HU 182562B
Authority
HU
Hungary
Prior art keywords
formula
lower alkyl
hydrochloride
piperidine
defined above
Prior art date
Application number
HU79PI678A
Other languages
German (de)
English (en)
Hungarian (hu)
Inventor
Simon F Campbell
John Ch Danilewicz
Colin W Greengrass
Rhon M Plews
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU182562B publication Critical patent/HU182562B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HU79PI678A 1978-05-18 1979-05-17 Process for preparing new 4-amino-2-piperidino-quinazoline derivatives HU182562B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2035178 1978-05-18

Publications (1)

Publication Number Publication Date
HU182562B true HU182562B (en) 1984-02-28

Family

ID=10144517

Family Applications (1)

Application Number Title Priority Date Filing Date
HU79PI678A HU182562B (en) 1978-05-18 1979-05-17 Process for preparing new 4-amino-2-piperidino-quinazoline derivatives

Country Status (30)

Country Link
US (1) US4243666A (xx)
JP (1) JPS554370A (xx)
AR (2) AR223487A1 (xx)
AT (1) ATA363379A (xx)
AU (1) AU512947B2 (xx)
BE (1) BE876297A (xx)
CA (1) CA1240325A (xx)
CH (1) CH643553A5 (xx)
CS (1) CS214796B2 (xx)
DD (1) DD143613A5 (xx)
DE (1) DE2919800A1 (xx)
DK (1) DK159079A (xx)
ES (2) ES480671A1 (xx)
FI (1) FI64589C (xx)
FR (1) FR2434162A1 (xx)
GR (1) GR72824B (xx)
HU (1) HU182562B (xx)
IL (1) IL57297A (xx)
IN (1) IN153045B (xx)
IT (1) IT1114222B (xx)
LU (1) LU81284A1 (xx)
NL (1) NL172157C (xx)
NO (1) NO791648L (xx)
NZ (1) NZ190465A (xx)
PH (1) PH14802A (xx)
PL (2) PL121158B1 (xx)
PT (1) PT69622A (xx)
SE (1) SE439306B (xx)
YU (2) YU115279A (xx)
ZA (1) ZA792390B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607034A (en) * 1979-10-29 1986-08-19 Mitsubishi Yuka Pharmaceutical Co., Ltd. Quinazoline derivatives and pharmaceutical composition thereof
JPS5962766U (ja) * 1982-06-30 1984-04-25 守田 智 小動物用給水器
GB8414518D0 (en) * 1984-06-07 1984-07-11 Pfizer Ltd Therapeutic agents
US5801195A (en) * 1994-12-30 1998-09-01 Celgene Corporation Immunotherapeutic aryl amides
US6248888B1 (en) 1997-11-14 2001-06-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of terazosin hydrochloride dihydrate
WO2002057235A1 (fr) * 2001-01-18 2002-07-25 Takeda Chemical Industries, Ltd. Procede de preparation de composes de benzylpiperidine
US6746460B2 (en) * 2002-08-07 2004-06-08 Satiety, Inc. Intra-gastric fastening devices
EP1685115A1 (en) * 2003-11-03 2006-08-02 Warner-Lambert Company LLC Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
TW200831497A (en) * 2006-10-12 2008-08-01 Epix Delaware Inc Carboxamide compounds and their use
KR101441930B1 (ko) * 2007-04-04 2014-09-19 시플라 리미티드 에르로티닙 및 그의 약학적으로 허용가능한 염의 제조방법
JP2011506466A (ja) * 2007-12-11 2011-03-03 株式会社サイトパスファインダー カルボキサミド化合物ならびにケモカイン受容体アゴニストとしてのそれらの使用
AU2009315761A1 (en) * 2008-11-14 2010-05-20 F. Hoffmann-La Roche Ag Quinazoline derivatives as NK3 receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
FR2321890A1 (fr) * 1975-08-26 1977-03-25 Synthelabo Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment
DK140695C (da) * 1976-05-07 1980-05-12 Synthelabo Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf

Also Published As

Publication number Publication date
PL120651B1 (en) 1982-03-31
FI64589B (fi) 1983-08-31
BE876297A (fr) 1979-11-16
IL57297A (en) 1983-02-23
ES488210A0 (es) 1980-12-16
DK159079A (da) 1979-11-19
SE439306B (sv) 1985-06-10
AU512947B2 (en) 1980-11-06
ATA363379A (de) 1983-05-15
ES8101584A1 (es) 1980-12-16
LU81284A1 (fr) 1980-12-16
CH643553A5 (de) 1984-06-15
NL172157B (nl) 1983-02-16
NL172157C (nl) 1983-07-18
FI64589C (fi) 1983-12-12
PL223844A1 (xx) 1981-01-02
FR2434162B1 (xx) 1983-04-22
PL121158B1 (en) 1982-04-30
CS214796B2 (en) 1982-05-28
AU4710179A (en) 1979-11-22
DD143613A5 (de) 1980-09-03
NL7903853A (nl) 1979-11-20
JPS5623992B2 (xx) 1981-06-03
NZ190465A (en) 1981-05-01
FI791562A (fi) 1979-11-19
IT1114222B (it) 1986-01-27
PT69622A (en) 1979-06-01
AR224784A1 (es) 1982-01-15
GR72824B (xx) 1983-12-06
IT7922720A0 (it) 1979-05-16
JPS554370A (en) 1980-01-12
PH14802A (en) 1981-12-14
YU115279A (en) 1983-04-30
CA1240325A (en) 1988-08-09
DE2919800A1 (de) 1979-11-22
IL57297A0 (en) 1979-09-30
PL215626A1 (xx) 1980-08-25
SE7904358L (sv) 1979-11-19
ES480671A1 (es) 1980-08-16
IN153045B (xx) 1984-05-26
NO791648L (no) 1979-11-20
FR2434162A1 (fr) 1980-03-21
AR223487A1 (es) 1981-08-31
US4243666A (en) 1981-01-06
ZA792390B (en) 1980-07-30
YU256382A (en) 1983-04-30

Similar Documents

Publication Publication Date Title
RU2086549C1 (ru) Производные бис-бензо- или бензопиридо-циклогептапиперидина, пиперидилидена и пеперазина и фармацевтическая композиция на их основе
AU646519B2 (en) Pyridine and pyridine N-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof
US4289772A (en) 1-Piperidinophthalazines as cardiac stimulants
US4686228A (en) Quinoline therapeutic agents
US5985894A (en) N-substituted quinolines
JP2002515486A (ja) 掻痒性皮膚病の治療用の新規4−フェニルピペリジン
CS223977B2 (en) Method of preparation of the chinazoline derivatives
CS228506B2 (en) Method for the production of optical active ester of 1,4-dihydropyridincarboxyl acid
US5212182A (en) Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
JP2001512118A (ja) オキシドスクアレン−シクラーゼを阻害するピリジル−およびピリミジル複素環式化合物
US4188391A (en) 4-[4-(Substituted)piperidino]quinazoline cardiac stimulants
JPS59219260A (ja) 新規なナフタレン−およびアザナフタレン−カルボキサミド誘導体、それを含有する製薬学的組成物、並びにそれらの製造法
JPS6289679A (ja) ピペリジン誘導体
FI110940B (fi) Menetelmä terapeuttisesti aktiivisten kinoloni- ja akridonijohdannaisten valmistamiseksi
HU182562B (en) Process for preparing new 4-amino-2-piperidino-quinazoline derivatives
JP2001518906A (ja) セロトニン様作用薬としてのインダゾールアミド化合物
HU189271B (en) Process for producing new arene- and heteroarene-carbox-amide derivatives and pharmaceutical compositions containing them as active agents
US5670522A (en) Dopamine receptor subtype ligands
CZ396591A3 (en) Enantiomers of 1,4-dihydropyridine process of their preparation and pharmaceutical compositions prepared therefrom
PT86082B (pt) Processo para a preparacao de agentes di-hidropiridinicos anti-alergicos e anti-inflamatorios
NZ243337A (en) 1-piperidyl substituted quinoline derivatives and pharmaceutical compositions
EP1214299B1 (en) Muscarinic antagonists
JP2001511799A (ja) オキシド−スクアレンシクラーゼ阻害剤として有用なヘテロ環式化合物
EP0201085A2 (en) 6-Phenyl-1,2,3,4,4a,5,6,10b-octahydrobenz(h) isoquinolines
JP2546919B2 (ja) 9ーアシルアミノテトラヒドロアクリジン誘導体